EA201590718A1 - Способы получения макроциклических депсипептидов с использованием ацетальальдегида и новые промежуточные соединения - Google Patents
Способы получения макроциклических депсипептидов с использованием ацетальальдегида и новые промежуточные соединенияInfo
- Publication number
- EA201590718A1 EA201590718A1 EA201590718A EA201590718A EA201590718A1 EA 201590718 A1 EA201590718 A1 EA 201590718A1 EA 201590718 A EA201590718 A EA 201590718A EA 201590718 A EA201590718 A EA 201590718A EA 201590718 A1 EA201590718 A1 EA 201590718A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- depypeptides
- acetalaldehyde
- methods
- new intermediate
- intermediate connections
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 108010002156 Depsipeptides Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/164—Unsaturated ethers containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261711282P | 2012-10-09 | 2012-10-09 | |
PCT/IB2013/059197 WO2014057419A2 (en) | 2012-10-09 | 2013-10-08 | Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201590718A1 true EA201590718A1 (ru) | 2015-07-30 |
Family
ID=49880855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201590718A EA201590718A1 (ru) | 2012-10-09 | 2013-10-08 | Способы получения макроциклических депсипептидов с использованием ацетальальдегида и новые промежуточные соединения |
Country Status (14)
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2632392T3 (es) | 2007-08-17 | 2017-09-12 | Novartis Ag | Depsipéptidos cíclicos |
AR086168A1 (es) | 2011-04-20 | 2013-11-27 | Novartis Ag | Procesos para la elaboracion de depsipeptidos macrociclicos e intermediarios |
US8680054B2 (en) | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
US9067978B2 (en) | 2012-10-09 | 2015-06-30 | Novartis Ag | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
CN106029684A (zh) * | 2014-04-08 | 2016-10-12 | 诺华股份有限公司 | 用于生产大环缩酚酸肽和新中间体的新型缩醛类方法 |
US20190062260A1 (en) * | 2017-08-31 | 2019-02-28 | Rohm And Haas Company | Antimicrobial compositions, methods of making, and methods of use |
US11643438B2 (en) | 2018-07-20 | 2023-05-09 | The Board Of Regents Of The University Of Oklahoma | Antimicrobial peptides and methods of use |
CN111072622B (zh) * | 2019-12-27 | 2023-01-17 | 江苏广域化学有限公司 | 一种3-卤代丙醛的缩醛类化合物的合成方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3043252C2 (de) | 1980-11-15 | 1982-12-02 | Degussa Ag, 6000 Frankfurt | Cyclische Acetale von N-Acylglutaminsäure -γ- semialdehyden, Verfahren zu deren Herstellung und ihre Verwendung |
US5595756A (en) | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
DE4421113A1 (de) | 1994-06-16 | 1995-12-21 | Biotechnolog Forschung Gmbh | Chondramide, Gewinnungsverfahren, Mittel mit Chondramiden und Mischkultur zur Chondramid-Gewinnung |
DE19828043A1 (de) | 1998-06-24 | 1999-12-30 | Bayer Ag | Ektoparasitizide Mittel |
JP2000154198A (ja) | 1998-11-20 | 2000-06-06 | Nisshin Flour Milling Co Ltd | 環状デプシペプチドの固相合成方法及びその中間体 |
GB0108234D0 (en) | 2001-04-02 | 2001-05-23 | Pharma Mar Sa | Process for producing trunkamide A compounds |
US7662960B2 (en) * | 2001-04-26 | 2010-02-16 | Choongwae Pharma Corporation | Beta-strand mimetics and method relating thereto |
US20040110228A1 (en) | 2002-04-01 | 2004-06-10 | Mcalpine Shelli R. | Combinatorial organic synthesis of unique biologically active compounds |
PL1631295T3 (pl) | 2003-06-06 | 2010-09-30 | Arexis Ab | Zastosowanie skondensowanych związków heterocyklicznych jako inhibitorów SCCE do leczenia chorób skóry |
GB0322140D0 (en) | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
EP1716248A1 (en) | 2004-02-03 | 2006-11-02 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7) |
JP2009532664A (ja) | 2006-02-27 | 2009-09-10 | アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティ | 癌の治療のためのノボペプチドの同定および使用 |
JP5401459B2 (ja) | 2007-08-17 | 2014-01-29 | ノバルティス アーゲー | カリクレイン7を阻害するための環状デプシペプチドの使用 |
ES2632392T3 (es) | 2007-08-17 | 2017-09-12 | Novartis Ag | Depsipéptidos cíclicos |
DE102007052391A1 (de) | 2007-10-31 | 2009-05-07 | Henkel Ag & Co. Kgaa | Mattwachs |
US20110112121A1 (en) | 2009-07-06 | 2011-05-12 | Joerg Berghausen | Pharmaceutical Compositions and Solid Forms |
KR101004362B1 (ko) | 2010-03-19 | 2010-12-28 | 가톨릭대학교 산학협력단 | 자가 면역 질환 예방 및 치료용 TNF-α와 TWEAK 이중 길항제 |
US20120064136A1 (en) | 2010-09-10 | 2012-03-15 | Nanobio Corporation | Anti-aging and wrinkle treatment methods using nanoemulsion compositions |
WO2012035468A2 (en) | 2010-09-14 | 2012-03-22 | Trima - Israel Pharmaceutical Products Maabarot Ltd. | Foamable topical composition |
SG10201804552WA (en) | 2011-01-24 | 2018-07-30 | Anterios Inc | Nanoparticle compositions, formulations thereof, and uses therefor |
KR20140003572A (ko) | 2011-01-24 | 2014-01-09 | 안테리오스, 인코퍼레이티드 | 나노입자 조성물 |
AR086168A1 (es) * | 2011-04-20 | 2013-11-27 | Novartis Ag | Procesos para la elaboracion de depsipeptidos macrociclicos e intermediarios |
US8680054B2 (en) | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
US9067978B2 (en) | 2012-10-09 | 2015-06-30 | Novartis Ag | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
-
2013
- 2013-10-01 US US14/042,950 patent/US8987413B2/en active Active
- 2013-10-08 WO PCT/IB2013/059197 patent/WO2014057419A2/en active Application Filing
- 2013-10-08 EA EA201590718A patent/EA201590718A1/ru unknown
- 2013-10-08 CA CA2884401A patent/CA2884401A1/en not_active Abandoned
- 2013-10-08 EP EP13812093.6A patent/EP2906586A2/en not_active Withdrawn
- 2013-10-08 TW TW102136396A patent/TW201420596A/zh unknown
- 2013-10-08 MX MX2015004628A patent/MX2015004628A/es unknown
- 2013-10-08 KR KR1020157008835A patent/KR20150065710A/ko not_active Withdrawn
- 2013-10-08 CN CN201380052592.5A patent/CN104797592A/zh active Pending
- 2013-10-08 AU AU2013328285A patent/AU2013328285B2/en not_active Ceased
- 2013-10-08 JP JP2015535163A patent/JP2016500668A/ja active Pending
- 2013-10-08 BR BR112015006293A patent/BR112015006293A2/pt not_active IP Right Cessation
- 2013-10-08 IN IN1812DEN2015 patent/IN2015DN01812A/en unknown
- 2013-10-09 AR ARP130103657A patent/AR092951A1/es unknown
-
2015
- 2015-01-14 US US14/596,561 patent/US20150141615A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2013328285B2 (en) | 2016-07-14 |
WO2014057419A2 (en) | 2014-04-17 |
IN2015DN01812A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-05-29 |
WO2014057419A3 (en) | 2014-07-03 |
AR092951A1 (es) | 2015-05-06 |
CN104797592A (zh) | 2015-07-22 |
AU2013328285A1 (en) | 2015-03-12 |
US20140100353A1 (en) | 2014-04-10 |
BR112015006293A2 (pt) | 2017-07-04 |
EP2906586A2 (en) | 2015-08-19 |
US20150141615A1 (en) | 2015-05-21 |
JP2016500668A (ja) | 2016-01-14 |
KR20150065710A (ko) | 2015-06-15 |
TW201420596A (zh) | 2014-06-01 |
US8987413B2 (en) | 2015-03-24 |
MX2015004628A (es) | 2015-07-14 |
CA2884401A1 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123958T1 (el) | Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης | |
EA201590718A1 (ru) | Способы получения макроциклических депсипептидов с использованием ацетальальдегида и новые промежуточные соединения | |
EA201590698A1 (ru) | Жидкофазные способы получения макроциклических депсипептидов и новые промежуточные соединения | |
EA201491811A1 (ru) | АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ | |
EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
EA201391554A1 (ru) | Способы получения макроциклических депсипептидов и новых промежуточных соединений | |
IT1400544B1 (it) | Procedimento di detossificazione di tessuto biologico. | |
EA201491224A1 (ru) | Анти-псф-тау-антитела и их применение | |
CL2016001190A1 (es) | Cultivo de células de mamífero. | |
CL2015001054A1 (es) | Métodos de cultivo de microorganismos en condiciones mixotrópicas no axénicas. | |
EA201491947A1 (ru) | Антитела и иммуноконъюгаты к ly6e и способы применения | |
EA201391274A1 (ru) | Аминохинолины в качестве ингибиторов киназ | |
EA201891264A2 (ru) | Антагонисты st2l и способы их применения | |
EA201270149A1 (ru) | Ингибиторы bace | |
UY34342A (es) | ?derivados de pirrolopirimidina y purina?. | |
EA201391041A1 (ru) | Растворимые в воде мембранные белки и способы их получения и применения | |
UA111827C2 (uk) | Спосіб отримання інгенол-3-ангелату | |
EA201301130A1 (ru) | Имидазопиридазины в качестве ингибиторов акт киназы | |
EA201391396A1 (ru) | Макроциклические соединения и способы их получения | |
EA201300443A1 (ru) | Способ получения дигидроптеридинонов и их промежуточных продуктов | |
EA201300432A1 (ru) | Полые микросферы и способ получения полых микросфер | |
EA201201670A1 (ru) | Циклический амин-азагетероциклический карбоксамид | |
EA201591742A1 (ru) | Способ улучшения диагностики заболеваний с использованием измеряемых аналитов | |
BR112013019046A2 (pt) | método de produção de partículas de catalisador, partículas de catalisador, e, uso das mesmas. | |
EA201690263A1 (ru) | Улучшенные способы получения перампанеля |